Rare Disease Gene Therapy Market

Key Players

• The Vanguard Group
• Alexion
• Allergen Plc
• Amgen
• Baxter
• Bayer
• Bristol-Myers Squibb
• F. Hoffmann-La Roche Ag
• Merck KGaA
• Novartis
• Novo Nordisk A/S
• L'Oréal
• Berkshire Hathaway
• Vertex Pharmaceuticals Incorporated